首页> 外文期刊>Pain. >Prostaglandin E2/EP4 signalling facilitates EP4 receptor externalization in primary sensory neurons in vitro and in vivo
【24h】

Prostaglandin E2/EP4 signalling facilitates EP4 receptor externalization in primary sensory neurons in vitro and in vivo

机译:前列腺素E2 / EP4信号在体内外促进初级感觉神经元中EP4受体的外在化

获取原文
获取原文并翻译 | 示例
           

摘要

Inflammatory pain severely affects the quality of life of millions of individuals worldwide. Prostaglandin E2 (PGE2), a pain mediator enriched in inflamed tissues, plays a pivotal role in nociceptor sensitization and in the genesis of inflammatory pain. Its EP4 receptor mainly mediates its role in inflammatory pain. However, the underlying mechanisms are poorly understood. Here we found that PGE2/EP4 signalling-induced EP4 externalization in dorsal root ganglion (DRG) neurons contributes to nociceptor sensitization and inflammatory pain. In cultured DRG neurons, PGE2 and the EP4 agonist concentration- and time-dependently stimulated EP4 externalization. The inhibitors of anterograde secretory pathway, protein synthesis, or recycling pathway suppressed PGE2-induced EP4 externalization, suggesting that EP4 retained in Golgi apparatus and in recycling endosomes, as well as newly synthesized, are mobilized in this event. Interestingly, the intracellular cAMP levels of cultured DRG explants following 2 sequential treatments with the EP4 agonist were significantly higher than a single treatment, suggesting that the first treatment of agonist likely induces EP4 export to sensitize DRG neurons. Intraplantar injection of complete Freud's adjuvant increases both total and cell-surface EP4 levels of L4-6 DRG neurons, an event suppressed by a cyclooxygenase-2 inhibitor or a selective EP4 antagonist, suggesting that PGE2/EP4 signalling in inflamed paw contributes to EP4 synthesis and export in DRG neurons, thus sensitizing nociceptors during inflammation. We conclude that PGE2/EP4 signalling-induced EP4 externalization in DRG neuron is a novel mechanism underlying nociceptor sensitization and inflammatory pain. Blocking EP4 externalization could open a novel therapeutic avenue to treat inflammatory pain. ? 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
机译:炎性疼痛严重影响着全球数百万人的生活质量。前列腺素E2(PGE2)是一种富含炎症组织的疼痛介质,在伤害感受器敏化和炎症性疼痛的发生中起关键作用。它的EP4受体主要介导其在炎性疼痛中的作用。但是,基本机制了解得很少。在这里,我们发现在背根神经节(DRG)神经元中PGE2 / EP4信号诱导的EP4外部化有助于伤害感受器敏化和炎性疼痛。在培养的DRG神经元中,PGE2和EP4激动剂的浓度和时间依赖性刺激了EP4的外部化。顺行分泌途径,蛋白质合成或再循环途径的抑制剂抑制了PGE2诱导的EP4外部化,这表明在此事件中动员了保留在高尔基体和再循环内体以及新合成的EP4。有趣的是,经过两次连续的EP4激动剂处理后,培养的DRG外植体的细胞内cAMP水平明显高于单一处理,这表明第一次激动剂处理可能会诱导EP4出口,从而使DRG神经元敏感。足底内完全弗洛伊德佐剂的注射增加了L4-6 DRG神经元的总和细胞表面EP4水平,该事件被环氧合酶2抑制剂或选择性EP4拮抗剂抑制,表明发炎的爪子中的PGE2 / EP4信号传导有助于EP4的合成并在DRG神经元中输出,从而在炎症过程中使伤害感受器敏感。我们得出的结论是,DRG神经元中PGE2 / EP4信号诱导的EP4外在化是一种基于伤害感受器敏化和炎性疼痛的新型机制。阻止EP4外在化可以为治疗炎性疼痛开辟一条新的治疗途径。 ? 2012年国际疼痛研究协会。由Elsevier B.V.发布。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号